Marquette University
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Marquette University sits in the top decile of US sponsors by registered trial count (#583 of 15,742 sponsors by registered trial count).
Marquette University: 27 sponsored US clinical trials, 12 recruiting.
Marquette University sponsors 27 registered US clinical trials on ClinicalTrials.gov, 12 of them currently recruiting, and 12 completed. 2 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Aging, with 2 trials.
Top-decile sponsor footprint
Marquette University ranks in the top decile of sponsors by registered trial count (#583 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
12 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
27 total, page 1 of 1
Pain in Aging Former Athletes, Master's Athletes, and Nonathletes
NCT07502742
Determinants of Bone Dimensional Changes After Extraction and Alveolar Ridge Preservation
NCT06624982
Mental Imagery to Improve Quadriceps Strength Post Anterior Cruciate Ligament Reconstruction: a Feasibility Study
NCT06858293
Computer-guided Action Planning to Support Physical Activity (CAPPA) for Employees with Chronic Knee Symptoms
NCT06734052
Exercise Training in Children With Communication Impairments
NCT06340893
Preemptive Ibuprofen Effects on Pain Perception Following Extraction and Bone Graft
NCT05919745
Perception of Speech in Context by Listeners With Healthy and Impaired Hearing
NCT06465979
CUped: An Approach to Motor Recovery Post-Stroke, Not Compensation
NCT06329765
Use of Sensory Substitution to Improve Arm Control After Stroke
NCT03298243
High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis
NCT05735691
Life After Sport: Prior Injury and Sedentary Behavior as Mechanisms of Later Poor Health
NCT05344001
Fatigability of Lower Limb Muscle in Older Adults: Protective Effects of Strength Training Exercise in Old Men and Women
NCT03888040
Dose Frequency RCT on DTTC in Children With CAS
NCT05675306
The Efficacy of Probiotics to Reduce Antepartum Group B Streptococcus Colonization.
NCT03696953
Wound Healing Following Extraction and Ridge Preservation in Smokers and Non-smokers
NCT07372183
Addressing Arm Non-use by Encouraging Idle-time Activity During Early Recovery From Stroke
NCT05900999
Feasibility of a Yoga Program for Veterans With PTSD
NCT05177757
Isometric Exercise and Endogenous Pain Inhibition
NCT03778476
Photobiomodulation Therapy in Persons With Multiple Sclerosis
NCT03691766
Powertoothbrushing for Treating Gingivitis
NCT03381339
Dietary Analysis for Caries Prevention in Children Using a Computer Software
NCT02375763
ADHD Treatment for Latino Families
NCT02317692
READI (Readiness Evaluation And Discharge Interventions) Study
NCT01873118
The CARS Study: Communicating About Readiness (for Discharge)
NCT01873105
Project Fun: Parents And Youth Together
NCT01799759
Quasi Experiment of Prenatal Probiotics Against Group B Streptococcus Colonization
NCT02249325
Comparison of Two Internet Supported Natural Family Planning Methods
NCT00843336
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Where Marquette University enrollment is open (later-stage tilt)
12 recruiting of 27 indexed (44% open); 12 completed (44%).
Phase mix: 2 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Aging (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Marquette University: open-pipeline peers nationwide
Peers matched on 27 registered trials and 44% open enrollment, not the therapeutic-area sidebar.
Marquette University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 27 trials (± recruiting share)
- Akron Children's Hospital · 27 trials · 7% recruiting
- ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) · 27 trials · 0% recruiting
- AVEO Pharmaceuticals · 27 trials · 7% recruiting
- Dompé Farmaceutici S.p.A · 27 trials · 15% recruiting
Sponsors near 44% open enrollment (± trial volume)
- 4D Molecular Therapeutics · 44% recruiting · 9 trials
- American Heart Association · 44% recruiting · 9 trials
- Ascendis Pharma A/S · 44% recruiting · 9 trials
- Cullinan Therapeutics · 44% recruiting · 9 trials
Related
What to do with this Marquette University page
27 registered trials is a research-attention snapshot, not an endorsement of Marquette University or any single study.
- 12 of Marquette University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Aging is the condition Marquette University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aging trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Marquette University pipeline card: 27 registered trials from official public datasets.Report a data error.